Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 2

Status

Unknown 6Recruiting 2Not yet recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 4OTHER_GOV 2

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 12Thoracic 6Endocrine 3Head & Neck 2Breast 2Sarcoma 1Other solid neoplasm 1NET 1

Conditions

Small Cell Lung Carcinoma 4Stomach Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Advanced Non-Small Cell Lung Cancer 1

Interventions

Carboplatin 132Cisplatin 129Pemetrexed 114Docetaxel 81Drug Therapy 62Gefitinib 57anlotinib 55Gemcitabine 55Erlotinib Hydrochloride 55Radiotherapy 48Bevacizumab 48pembrolizumab 47Paclitaxel 47Etoposide 44apatinib 42icotinib 41camrelizumab 39osimertinib 36Nivolumab 33Vinorelbine 31Radiosurgery 30sintilimab 29durvalumab 25aumolertinib 25endostar protein 24atezolizumab 22Endostatins 22toripalimab 19Blood Specimen Collection 19tislelizumab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × surufatinib × Thoracic × Clear all
NCT04922658 2024-07-31

Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer

Affiliated Cancer Hospital & Institute of Guangzhou Medical University

Phase 2 Unknown
60 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

NCT05882630 2023-05-31

Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer

Fujian Cancer Hospital

Phase 1/2 Unknown
39 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT05595889 2022-11-29

Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung Cancer

Fujian Cancer Hospital

Phase 2 Unknown
40 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT04996771 2022-11-14

Surufatinib Combined With Chemotherapy Plus Toripalimab or Not in the Treatment of Small Cell Lung Cancer

Sun Yat-sen University

Phase 1/2 Unknown
88 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT05003037 2022-11-04

Surufatinib Combined With Toripalimab and Chemotherapy in the Treatment of Non-Small Cell Lung Cancer

Sun Yat-sen University

Phase 2 Unknown
106 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05527821 2022-09-06

Study of Surufatinib Combined With Sintilimab and SCRT in Advanced Solid Tumors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 2 Unknown
36 enrolled
GastrointestinalThoracic

Stomach Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡